Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy

AIDS. 2003 Jul 4;17(10):1503-11. doi: 10.1097/00002030-200307040-00011.

Abstract

Objectives: Adipocytokines, secreted by adipose tissue, may regulate fat metabolism, lipid and glucose homeostasis and insulin sensitivity. We analysed the relations between circulating concentrations of adiponectin, leptin, interleukin-6, tumor necrosis factor alpha and its soluble receptors sTNFR1 and R2, lipodystrophic phenotypes and metabolic alterations in patients under highly active antiretroviral therapy (HAART).

Methods: We studied 131 consecutive HIV-infected males under protease inhibitor (PI)-based HAART, with body mass index < 27 kg/m2 and C-reactive protein (CRP) < 10 mg/l. Patients were classified in four groups according to clinical examination: no lipodystrophy (NL), lipohypertrophy (LH), lipoatrophy (LA) and mixed lipodystrophy (ML). In addition to adipocytokines, we measured plasma fasting levels of triglycerides, cholesterol, cardiovascular risk markers (high-sensitivity CRP and apolipoproteins B/A1 ratio), fasted and 2 h post-glucose loading glycemia and insulinemia and calculated the quantitative insulin sensitivity check index.

Results: The patients were HIV-infected and PI-treated for a mean of 8.2 and 1.6 years respectively; 74% presented lipodystrophy, 38% altered glucose tolerance and 42% hypertriglyceridemia. Insulin sensitivity correlated positively with adiponectin and negatively with leptin and interleukin-6. Adiponectin, but not leptin, negatively correlated with all metabolic parameters. Insulin resistance, metabolic defects and cardiovascular risk markers were strongly negatively correlated with the adiponectin/leptin ratio (A/L), and positively with sTNFR1. LA patients had a longer duration of infection but ML patients presented the most severe metabolic alterations, insulin resistance and A/L decrease.

Conclusions: These results suggest that adiponectin and the TNFalpha system are related to lipodystrophy, insulin resistance and metabolic alterations in patients under PI-based HAART. A/L and sTNFR1 could predict insulin sensitivity and potential cardiovascular risk in these patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin
  • Adipose Tissue / immunology*
  • Adult
  • Aged
  • Anti-HIV Agents / therapeutic use*
  • Antigens, CD / blood
  • Antiretroviral Therapy, Highly Active
  • Apolipoproteins A / analysis
  • Apolipoproteins B / analysis
  • C-Reactive Protein / analysis
  • Cholesterol / blood
  • Cytokines / blood*
  • HIV Infections / drug therapy
  • HIV-1*
  • HIV-Associated Lipodystrophy Syndrome / blood
  • HIV-Associated Lipodystrophy Syndrome / drug therapy
  • HIV-Associated Lipodystrophy Syndrome / immunology*
  • Humans
  • Intercellular Signaling Peptides and Proteins*
  • Interleukin-6 / blood
  • Leptin / blood
  • Male
  • Middle Aged
  • Proteins / analysis
  • Receptors, Tumor Necrosis Factor / blood
  • Receptors, Tumor Necrosis Factor, Type I
  • Receptors, Tumor Necrosis Factor, Type II
  • Regression Analysis
  • Triglycerides / blood
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Adiponectin
  • Anti-HIV Agents
  • Antigens, CD
  • Apolipoproteins A
  • Apolipoproteins B
  • Cytokines
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-6
  • Leptin
  • Proteins
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Receptors, Tumor Necrosis Factor, Type II
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein
  • Cholesterol